Hemangioma: Clinical Trials

162 trials for Hemangioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 completed, 23 terminated, 20 recruiting, 14 unknown. 48 Phase 2, 31 Not applicable, 15 Phase 1, 13 Phase 3, 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 248Completed 26, Terminated 9, Recruiting 5, Not yet recruiting 3, Unknown 2, Withdrawn 2, Active not recruiting 1
Not applicable31Completed 17, Recruiting 5, Terminated 3, Not yet recruiting 2, Active not recruiting 1, Suspended 1, Unknown 1, Withdrawn 1
Phase 115Completed 8, Terminated 3, Recruiting 2, Not yet recruiting 1, Unknown 1
Phase 313Completed 7, Recruiting 3, Terminated 2, Unknown 1
Phase 49Completed 5, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1
Early Phase 15Terminated 4, Not yet recruiting 1

Follow Hemangioma: new trials by email Literature Review of Hemangioma trials Research Report on Hemangioma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Rapamycin cream, Pulsed dyed laser - Port Wine Stains
Phase 2Not yet recruitingAFT Pharmaceuticals, Ltd.302026-11-132026-10-27
Study to Establish Safety, Tolerability and Pharmacokinetics of NRL-1049 in Healthy Adult Participants Following Multiple-Dose Administration
NRL-1049, Placebo - Cerebral Cavernous Malformation
Phase 1Not yet recruitingNeurelis, Inc.402026-11-112026-10-30
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin
Phase 3RecruitingMemorial Sloan Kettering Cancer Center140002026-10-152026-10-22
Preoperative Embolization for Highly Vascular Brain Tumors
Preoperative Endovascular Embolization - Brain Neoplasms, Meningioma
Not applicableNot yet recruitingAssiut University552026-10-012026-09-17
Neurocutaneous Syndromes in Children: Prevalence and Clinical Characteristics
Sturge-Weber Syndrome, Neurocutaneous Syndromes
Not yet recruitingAssiut University1002026-09-202026-09-28
A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma
Sirolimus for injection (Albumin-bound) - Epithelioid Hemangioendothelioma
Phase 2Not yet recruitingCSPC ZhongQi Pharmaceutical Technology Co., Ltd.402026-08-012026-07-06
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
Pulse Dye laser, Pulse Dye Laser (PDL) pulse width stacking, Pulse Dye Laser (PDL) followed by Nd:YAG (Neodymium-doped Yttrium Aluminum Garnet laser) laser. - Port Wine Stains
Not applicableRecruitingUniversity of Texas Southwestern Medical Center2002026-07-012026-06-05
Abrupt Discontinuation Versus Gradual Tapering of Propranolol in Infantile Hemangioma
Abrupt Discontinuation of Propranolol, Gradual Tapering of Propranolol - Infantile Hemangioma (IH)
Phase 4Not yet recruitingWest China Hospital1102026-07-012026-06-24
Biological Collection of the Rare Diseases of the Brain and Eye Vessels Cohort - 2
Biocollection, Neurological evaluation and Biocollection - CADASIL, Cavernous Angioma
Not applicableNot yet recruitingAssistance Publique - Hôpitaux de Paris6002026-06-302026-06-16
Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested Growth
Routine Clinical Assessment and Risk Stratification - Infantile Hemangioma (IH)
Not yet recruitingWest China Hospital1502026-06-202026-07-02
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
Sirolimus (RAPAMUNE) - Kaposiform Hemangioendothelioma (KHE), Kasabach Merritt Phenomenon
Phase 2 / Phase 3RecruitingYi Ji762026-06-162026-06-18
Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas
MRI - LUMBAR Syndrome
Not yet recruitingWest China Hospital702026-06-012026-06-01
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Everolimus - Vascular Malformations, Arteriovenous Malformations
Phase 2Not yet recruitingYonsei University672026-04-012026-03-17
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
nab-Sirolimus - Epithelioid Hemangioendothelioma (EHE)
Phase 2RecruitingSarcoma Alliance for Research through Collaboration412026-02-242026-05-26
Radiological Diagnosis of Pediatric Neck Swellings
Lipoma, Branchial Cleft Anomalies
Active not recruitingSohag University502026-02-202026-07-30
Fluctuational Imaging for the Diagnosis of Hepatic Hemangioma: A Multicenter, Prospective Study
Hemangioma
RecruitingYonsei University4002026-01-022026-02-18
Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study
Daratumumab - Cavernous Malformation, Cerebral
Early Phase 1Not yet recruitingBeijing Tiantan Hospital102025-07-012025-06-18
Aggressive Spinal Hemangioma
Aggressive Spinal Hemangiomas
Not yet recruitingAssiut University302025-06-302025-05-30
Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
Enchondromatosis
RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1002025-01-272026-10-01
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
propranolol - Infantile Hemangioma
Phase 2 / Phase 3RecruitingWest China Hospital322025-01-012026-09-21

Showing 20 of 162. Sign in to see all of them.

Narrower conditions

Hemangioma, Capillary (47)  ·  Sturge-Weber Syndrome (17)  ·  Hemangioblastoma (16)  ·  Hemangioma, Cavernous, Central Nervous System (16)  ·  Hemangioendothelioma, Epithelioid (13)  ·  von Hippel-Lindau Disease (11)  ·  Vascular Malformations (9)  ·  Hemangiosarcoma (8)  ·  Sarcoma (8)  ·  Arteriovenous Malformations (7)  ·  Hemangioma, Cavernous (7)  ·  Port-Wine Stain (7)  ·  Hemangioendothelioma (6)  ·  Kaposiform Hemangioendothelioma (6)

Broader conditions

Neoplasms by Histologic Type (162)  ·  Neoplasms, Vascular Tissue (162)  ·  Neoplasms (159)  ·  Cardiovascular Diseases (64)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (61)  ·  Nervous System Diseases (61)  ·  Congenital Abnormalities (57)  ·  Vascular Diseases (56)  ·  Hemic and Lymphatic Diseases (33)  ·  Cardiovascular Abnormalities (32)  ·  Central Nervous System Diseases (31)  ·  Brain Diseases (30)  ·  Angiomatosis (28)  ·  Hematologic Diseases (28)

Interventions

Propranolol (17)  ·  Timolol (10)  ·  Sirolimus (8)  ·  Prednisolone (6)  ·  Adrenergic beta-Antagonists (3)  ·  Lasers, Dye (3)  ·  Methylprednisolone (3)  ·  Prednisone (3)  ·  Sunitinib (3)  ·  Adrenal Cortex Hormones (2)  ·  Atenolol (2)  ·  Bleomycin (2)  ·  Blood Specimen Collection (2)  ·  Cannabidiol (2)  ·  Doxorubicin (2)

Sponsors

West China Hospital (9)  ·  Medical College of Wisconsin (6)  ·  Assiut University (4)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (4)  ·  University of California, Irvine (4)  ·  Anne Comi, MD (3)  ·  M.D. Anderson Cancer Center (3)  ·  The Hospital for Sick Children (3)  ·  University Hospital, Montpellier (3)  ·  University of California, San Francisco (3)  ·  University of Chicago (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Beijing Tiantan Hospital (2)  ·  Boston Children's Hospital (2)  ·  Children's Hospital of Fudan University (2)

Countries

United States (80)  ·  China (24)  ·  France (17)  ·  Canada (8)  ·  Spain (7)  ·  Italy (5)  ·  United Kingdom (5)  ·  Egypt (4)  ·  Germany (4)  ·  Brazil (3)  ·  Poland (3)  ·  Russia (3)  ·  South Korea (3)  ·  Australia (2)  ·  Austria (2)

Top investigators

Beth Drolet, MD (4)  ·  Anne M Comi, M.D. (3)  ·  Maria Garzon, MD (3)  ·  Yi Ji, MD, PhD (3)  ·  Anne Lucky, MD (2)  ·  Anne M Comi, MD (2)  ·  Beth A Drolet, MD (2)  ·  Denise Adams, MD (2)  ·  Denise Metry, MD (2)  ·  Eric Jonasch, MD (2)  ·  Eulalia Baselga, MD (2)  ·  Ilona J Frieden, MD (2)  ·  Issam A Awad, MD (2)  ·  Issam Awad, MD (2)  ·  Julie Powell, MD (2)

Results publications

PMID 35030255, PMID 22871490, PMID 28486787, PMID 31401903, PMID 31489702, PMID 32014025, PMID 33580918, PMID 19419474, PMID 19833796, PMID 20157038, PMID 20598318, PMID 20828712, PMID 22105611, PMID 22456397, PMID 23301692, PMID 23455486, PMID 24323376, PMID 24347141, PMID 24401931, PMID 24526257, PMID 24579662, PMID 24614374, PMID 24949994, PMID 25007365, PMID 25472749, PMID 25556204, PMID 25565562, PMID 25693013, PMID 26039810, PMID 26649337, PMID 26795600, PMID 26813215, PMID 26916576, PMID 26926644, PMID 27062495, PMID 27235002, PMID 27272077, PMID 27522443, PMID 27885682, PMID 28095550, PMID 28137820, PMID 28213875, PMID 28290120, PMID 28318403, PMID 28387823, PMID 28423174, PMID 28489816, PMID 28534135, PMID 28541265, PMID 28779462

NIH funding

U54NS065705 (5), 2008 (1), 2017 (1), 2025 (1), N01CM62206 (1), P30CA008748 (1), P30CA046592 (1), R01CA293974 (1), R01GM095657 (1), R01NS114552 (1), U01CA069856 (1), U01NS104157 (1), ZIAEB000073 (1)